why BioAffinity Technologies Inc [BIAF] is a Good Choice for Investors After New Price Target of $6.00

HOOK Stock

BioAffinity Technologies Inc [NASDAQ: BIAF] gained 10.06% or 0.03 points to close at $0.29 with a heavy trading volume of 5081152 shares.

The daily chart for BIAF points out that the company has recorded -67.41% loss over the past six months.

If we look at the average trading volume of 7.34M shares, BIAF reached to a volume of 5081152 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about BioAffinity Technologies Inc [BIAF]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BIAF shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BIAF stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

The Price to Book ratio for the last quarter was 3.68, with the Price to Cash per share for the same quarter was set at 0.02.

Trading performance analysis for BIAF stock

BioAffinity Technologies Inc [BIAF] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 18.37. With this latest performance, BIAF shares gained by 10.39% in over the last four-week period, additionally sinking by -67.41% over the last 6 months – not to mention a drop of -68.13% in the past year of trading.

BioAffinity Technologies Inc [BIAF]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and BioAffinity Technologies Inc [BIAF] shares currently have an operating margin of -109.38% and a Gross Margin at 27.48%. BioAffinity Technologies Inc’s Net Margin is presently recorded at -110.55%.

Return on Equity for this stock declined to -143.25%, with Return on Assets sitting at -143.25%.

An analysis of Institutional ownership at BioAffinity Technologies Inc [BIAF]

The top three institutional holders of BIAF stocks are: VANGUARD GROUP INC with ownership of 0.17 million shares, which is approximately 1.5101%. GEODE CAPITAL MANAGEMENT, LLC, holding 69600.0 shares of the stock with an approximate value of $$0.15 million in BIAF stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$60232.0 in BIAF stock with ownership which is approximately 0.2448%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.